From a UK perspective, BUD/F delivered via an MDI + VHC offers an economic benefit for the treatment of patients with mild asthma. Further analysis is required to determine if there would be any quality-adjusted life-year (QALY) effects based on the chosen intervention.
Medications to manage care of bronchiectasis and NTM patients are often delivered via a nebulizer. This study compares a number of different OPEP/Nebulizer combinations using salbutamol as the modelled medication.
Effective management of your COPD patients in COVID times - How to help keep them out of the hospital
We invite you to join in on the conversation with Dr. Alan Kaplan as he discusses COVID-19 risk for COPD patients, pharmacological and non-pharmacological COPD treatments, and tips for conducting virtual COPD visits.
We invite you to join the latest “Ask the Expert” session with Kathy Hayward, Respiratory Educator at Calgary COPD & Asthma Program, as she provides tips for how to best manage COPD, the importance of mucus clearance and inhaled medications, and the impact COVID-19 may have on COPD.
